⏳ Fetching live dividend data...
Home › Calculator › AVCO Dividend Calculator 2026
Avalon GloboCare Corp. · NASDAQ
Price: $0.53 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in AVCO → $286446901603868640.00M in 10 years · $23,864,447,051,280,590,000,000.00/month
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing RNA-based FASH-CARTM cell therapy platform. In addition, the company develops avalon clinical-grade tissue-specific exosome (ACTEX); offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Further, it has strategic partnership with the University of Natural Resources and Life Sciences in Vienna and Austria to develop an S-layer vaccine that could be administered by an intranasal or oral route against SARS-CoV-2 and coronavirus that causes COVID-19 disease; and develops Avalon Cell and Avalon Rehab, as well as promotes standardization related to exosome industry. The company is headquartered in Freehold, New Jersey.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open AVCO position with:
Real after-tax yield depends on where you live and how you hold AVCO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 380.30% | 377.50% | $38,030 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 323.25% | 320.45% | $32,325 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 304.24% | 301.44% | $30,424 / yr |
| 🇬🇧 UK ISA | 0% | 380.30% | 377.50% | $38,030 / yr |
| 🇬🇧 UK Taxable | 8.75% | 347.02% | 344.22% | $34,702 / yr |
| 🇨🇦 TFSA | 0% | 380.30% | 377.50% | $38,030 / yr |
| 🇨🇦 CA Taxable | 25% | 285.23% | 282.43% | $28,523 / yr |
| 🇦🇺 Super (pension) | 15% | 323.25% | 320.45% | $32,325 / yr |
| 🇦🇺 AU Taxable | 30% | 266.21% | 263.41% | $26,621 / yr |
| 🇩🇪 DE Taxable | 26.375% | 280.00% | 277.20% | $28,000 / yr |
| 🇫🇷 FR Taxable | 30% | 266.21% | 263.41% | $26,621 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
AVCO pays quarterly — 4 times per year. Next ex-div: TBD.
How AVCO compares to typical Real Estate averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AVCO sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2021-11-01 | 8,000 | $10.30 | $82.4K | ||
| A-Award | 2022-11-01 | 8,000 | $4.30 | $34.4K | ||
| A-Award | 2021-05-01 | 8,000 | $10.20 | $81.6K | ||
| A-Award | 2022-05-01 | 8,000 | $5.30 | $42.4K | ||
| A-Award | 2022-01-01 | 4,000 | $8.20 | $32.8K | ||
| A-Award | 2023-01-01 | 4,000 | $5.20 | $20.8K | ||
| A-Award | 2021-01-01 | 4,000 | $11.20 | $44.8K | ||
| A-Award | 2023-01-01 | 8,000 | $5.20 | $41.6K | ||
| A-Award | 2022-01-01 | 8,000 | $8.20 | $65.6K | ||
| A-Award | 2021-01-01 | 8,000 | $11.20 | $89.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AVCO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →